HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DIAGENS-B

450.000

+21.8005.09%

Volume:58.05K

Turnover:25.28M

Market Cap:40.00B

PE:-536.34

High:450.800

Open:410.000

Low:410.000

Close:428.200

52wk High:765.500

52wk Low:178.000

Shares:88.88M

HK Float Shares:88.88M

Volume Ratio:0.39

T/O Rate:0.07%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.839

ROE:-39.50%

ROA:-23.53%

PB:44.17

PE(LYR):-536.34

PS:186.74

Loading ...

Overview Company News Filings

Hangzhou Diagens proposes share incentive scheme featuring RSUs and stock options

Hangzhou Diagens proposes articles of association amendments after Hong Kong listing

DIAGENS-B Proposes Implementation of Share Incentive Scheme

DIAGENS-B Showcases Medical Imaging Base Model Capable of Slashing AI Development Costs by Over 90%

DIAGENS-B March 2026 Monthly Return Shows Stable Share Base and Public Float Compliance

Bulletin Express

Stock Track | DIAGENS-B Soars 5.41% Intraday on Strong Q1 Earnings and AI Product Regulatory Progress

Diagens adopts full electronic dissemination of corporate communications

Bulletin Express

DIAGENS-B Shares Surge Over 7% Again, AI AutoVision Nears Approval as First Domestic AI-Powered Chromosome Analysis Diagnostic Tool

Stock Track | DIAGENS-B Soars 5.60% Intraday on Strong Q1 Earnings Beat

Stock Track | DIAGENS-B Soars 6.24% Intraday on Strong Q1 Earnings and Positive Market Sentiment

Large Model Concept Stocks Show Strong Performance Before Noon, with DIAGENS-B and KNOWLEDGE ATLAS Both Rising Over 15%

DIAGENS-B Shares Surge Over 7% on Strong AI Medical Imaging Foundation Model

Diagens Issues FY2025 Results Notice; Full Annual Report to be Released by 30 April 2026

Bulletin Express

Medical Imaging AI Pioneer DIAGENS-B Soars 121% in Hong Kong IPO Debut

Hangzhou Diagens Biotechnology Soars 121% in Hong Kong Trading Debut

MT Newswires Live

Stock Track | DIAGENS-B Soars 113.94% on Trading Debut as Medical Imaging AI Firm Opens at Significant Premium to IPO Price

DIAGENS-B (02526) Debuts with 121.21% Surge in Early Trading, Focused on Medical Imaging AI Platform

Shares of Shandong Extreme Vision Set to Open at HK$59.95 Each in Hong Kong Debut VS Offer Price HK$40 Apiece

THOMSON REUTERS

Diagens Biotechnology Raises HK$719.8 Million From Hong Kong IPO Ahead of Debut

MT Newswires Live

Hangzhou Diagens Biotechnology - Final Offer Price of HK$99.0 per H Share

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/02526/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02526","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02526\",,,,,undefined,":{"symbol":"02526","market":"HK","secType":"STK","nameCN":"DIAGENS-B","latestPrice":450,"timestamp":1789027722238,"preClose":428.2,"halted":0,"volume":58050,"delay":0,"changeRate":0.050910789350770695,"floatShares":88879200,"shares":88879200,"eps":-0.839024,"marketStatus":"Closed","change":21.8,"latestTime":"09-10 16:08:42","open":410,"high":450.8,"low":410,"amount":25282430,"amplitude":0.095283,"askPrice":450,"askSize":350,"bidPrice":430,"bidSize":50,"shortable":0,"etf":0,"ttmEps":-1.576,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":5,"adr":0,"listingDate":1774800000000,"exchange":"SEHK","adjPreClose":428.2,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":0.386833,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02526\",,,,,undefined,":{"symbol":"02526","floatShares":88879200,"roa":"-23.53%","roe":"-39.50%","lyrEps":-0.839024,"volumeRatio":0.386833,"shares":88879200,"dividePrice":0,"high":450.8,"amplitude":0.095283,"preClose":428.2,"low":410,"week52Low":178,"pbRate":"44.17","psRate":"186.74","week52High":765.5,"institutionHeld":0,"latestPrice":450,"committee":-0.75,"eps":-0.839024,"divideRate":0,"volume":58050,"delay":0,"ttmEps":-1.576,"open":410,"prevYearClose":99,"prevWeekClose":495.6,"prevMonthClose":529,"prevQuarterClose":309.8,"fiveDayClose":504.5,"twentyDayClose":374,"sixtyDayClose":335},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02526\",params:#limit:5,,,undefined,":[{"date":"2026-08-07","symbol":"02526","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786066200000,"name":null,"time":"","dateTimestamp":1786032000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02526\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02526\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02526\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02526","date":"2026-09-09","current":-285.532995,"percent":0.917431,"low":-545.299386,"twenty":-394.984453,"median":-349.868766,"eighty":-312.635382,"high":-208.205701,"avg":-353.29623,"sd":64.739117,"marketCap":38058073440},"quantilePoints":[{"date":"2026-04-02","current":-272.27881,"twenty":-277.682472,"median":-258.576907,"eighty":-239.167269,"marketCap":20797732800},{"date":"2026-04-10","current":-346.403686,"twenty":-339.232012,"median":-285.787965,"eighty":-250.355764,"marketCap":26663760000},{"date":"2026-04-17","current":-325.713634,"twenty":-334.091876,"median":-317.126763,"eighty":-274.980641,"marketCap":25081710240},{"date":"2026-04-24","current":-330.080861,"twenty":-335.567541,"median":-326.636989,"eighty":-290.709378,"marketCap":25419451200},{"date":"2026-04-30","current":-332.18176,"twenty":-334.015312,"median":-325.713634,"eighty":-310.395031,"marketCap":25597209600},{"date":"2026-05-08","current":-379.447849,"twenty":-346.403686,"median":-328.46508,"eighty":-310.958904,"marketCap":29330136000},{"date":"2026-05-15","current":-344.735778,"twenty":-356.513965,"median":-332.396872,"eighty":-313.054502,"marketCap":26717087520},{"date":"2026-05-22","current":-402.3084,"twenty":-358.871836,"median":-336.827112,"eighty":-315.164028,"marketCap":31107720000},{"date":"2026-05-29","current":-406.641648,"twenty":-379.946058,"median":-343.048303,"eighty":-318.304405,"marketCap":31552116000},{"date":"2026-06-05","current":-360.299962,"twenty":-379.450143,"median":-344.735778,"eighty":-319.954129,"marketCap":27996948000},{"date":"2026-06-12","current":-372.447501,"twenty":-375.674905,"median":-349.027955,"eighty":-324.604965,"marketCap":28921291680},{"date":"2026-06-18","current":-353.616435,"twenty":-376.618141,"median":-353.630358,"eighty":-326.267647,"marketCap":27517000320},{"date":"2026-06-26","current":-343.086832,"twenty":-373.551497,"median":-351.652224,"eighty":-326.764376,"marketCap":26574880800},{"date":"2026-07-03","current":-355.442852,"twenty":-372.637829,"median":-352.781753,"eighty":-328.141924,"marketCap":27552552000},{"date":"2026-07-10","current":-525.783409,"twenty":-380.947063,"median":-353.887402,"eighty":-330.921221,"marketCap":40706673600},{"date":"2026-07-17","current":-330.366333,"twenty":-387.12216,"median":-355.442852,"eighty":-331.092504,"marketCap":25668312960},{"date":"2026-07-24","current":-307.647435,"twenty":-382.392854,"median":-353.630358,"eighty":-326.721913,"marketCap":23908504800},{"date":"2026-07-31","current":-369.618431,"twenty":-381.442978,"median":-353.199094,"eighty":-325.898305,"marketCap":28779084960},{"date":"2026-08-07","current":-476.223264,"twenty":-396.494596,"median":-354.130521,"eighty":-326.679451,"marketCap":37151505600},{"date":"2026-08-14","current":-232.289361,"twenty":-400.612159,"median":-353.887402,"eighty":-323.520825,"marketCap":32885304000},{"date":"2026-08-21","current":-329.499393,"twenty":-396.494596,"median":-352.781753,"eighty":-318.122472,"marketCap":46750459200},{"date":"2026-08-28","current":-306.753265,"twenty":-400.612159,"median":-352.216988,"eighty":-315.707365,"marketCap":43533032160},{"date":"2026-09-04","current":-310.261155,"twenty":-396.494596,"median":-351.396357,"eighty":-315.297789,"marketCap":44048531520},{"date":"2026-09-09","current":-267.65296,"twenty":-394.984453,"median":-349.868766,"eighty":-312.635382,"marketCap":38058073440}],"updateTime":1789053030628},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02526\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2631981845","title":"Hangzhou Diagens proposes share incentive scheme featuring RSUs and stock options","url":"https://stock-news.laohu8.com/highlight/detail?id=2631981845","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631981845?lang=en_us&edition=fundamental","pubTime":"2026-04-29 17:01","pubTimestamp":1777453281,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology proposed adoption of a share incentive scheme covering restricted share units and options.Board resolution dated April 29, 2026 set up shareholder vote at an AGM or EGM targeted for around June 2026.Awards would be settled using H shares bought in secondary market, newly issued H shares, or treasury shares.Company plans to publish a circular with meeting notice and scheme details.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Diagens Biotechnology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 29, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL3G234w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631904598","title":"Hangzhou Diagens proposes articles of association amendments after Hong Kong listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2631904598","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631904598?lang=en_us&edition=fundamental","pubTime":"2026-04-29 17:00","pubTimestamp":1777453243,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology proposed amendments to its articles of association, following regulatory updates and its March 30, 2026 Main Board listing in Hong Kong.Changes aim to align governance documents with updated PRC rules issued in March 2025.Revisions also reflect a post-IPO share capital structure of 88,879,200 shares, all H shares.Amendments require shareholder approval via special resolution at upcoming annual general meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Diagens Biotechnology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 29, 2026, and is solely responsible for the information ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL6FGGzP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129004203","title":"DIAGENS-B Proposes Implementation of Share Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1129004203","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129004203?lang=en_us&edition=fundamental","pubTime":"2026-04-29 16:52","pubTimestamp":1777452764,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526) has announced that its board of directors passed a resolution during a meeting held on April 29, 2026, recommending the adoption of a share incentive plan. The plan aims to foster...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","02526","BK1100","301122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165416316","title":"DIAGENS-B Showcases Medical Imaging Base Model Capable of Slashing AI Development Costs by Over 90%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165416316","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165416316?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:31","pubTimestamp":1776861069,"startTime":"0","endTime":"0","summary":"At the recent 2026 10th Everything Grows Conference, Hangzhou DIAGENS Biotechnology Co., Ltd. presented its self-developed iMedImage® medical imaging base model in the \"Hangzhou AI 18 Arhats\" joint...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","BK1189","BK1100","AIPO","AGIX","ARTY","CHAT","02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175371587","title":"DIAGENS-B March 2026 Monthly Return Shows Stable Share Base and Public Float Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1175371587","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175371587?lang=en_us&edition=fundamental","pubTime":"2026-04-22 17:08","pubTimestamp":1776848882,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B) filed a resubmitted monthly return with Hong Kong Exchanges and Clearing on 22 April 2026, covering the period to 31 March 2026—the company’s...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139693430","title":"Stock Track | DIAGENS-B Soars 5.41% Intraday on Strong Q1 Earnings and AI Product Regulatory Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=1139693430","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139693430?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:01","pubTimestamp":1776823280,"startTime":"0","endTime":"0","summary":"DIAGENS-B's stock price surged 5.41% during intraday trading on Wednesday, extending its recent positive momentum in the market.The significant upward movement appears driven by a combination of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187377963","title":"Diagens adopts full electronic dissemination of corporate communications","url":"https://stock-news.laohu8.com/highlight/detail?id=1187377963","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187377963?lang=en_us&edition=fundamental","pubTime":"2026-04-20 16:43","pubTimestamp":1776674625,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (Diagens) announced that, in line with Rule 2.07 of the Hong Kong Stock Exchange Listing Rules and the paperless listing regime effective since 31 December...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127375670","title":"DIAGENS-B Shares Surge Over 7% Again, AI AutoVision Nears Approval as First Domestic AI-Powered Chromosome Analysis Diagnostic Tool","url":"https://stock-news.laohu8.com/highlight/detail?id=1127375670","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127375670?lang=en_us&edition=fundamental","pubTime":"2026-04-20 10:30","pubTimestamp":1776652234,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526) saw its shares rise more than 7% again. As of the time of writing, the stock was up 6.02%, trading at HKD 299.2 with a turnover of HKD 27.43 million. Public information indicates...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIX","BK4585","ARTY","VGT","BK4588","BK1100","02526","CHAT","AIPO","VXUS","159180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109878773","title":"Stock Track | DIAGENS-B Soars 5.60% Intraday on Strong Q1 Earnings Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=1109878773","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109878773?lang=en_us&edition=fundamental","pubTime":"2026-04-20 09:48","pubTimestamp":1776649710,"startTime":"0","endTime":"0","summary":"DIAGENS-B's stock surged 5.60% during intraday trading on Monday, reflecting strong investor confidence in the company's latest financial performance.The significant price increase was primarily...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153309491","title":"Stock Track | DIAGENS-B Soars 6.24% Intraday on Strong Q1 Earnings and Positive Market Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1153309491","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153309491?lang=en_us&edition=fundamental","pubTime":"2026-04-16 11:59","pubTimestamp":1776311970,"startTime":"0","endTime":"0","summary":"DIAGENS-B's stock surged 6.24% during intraday trading on Thursday, reflecting significant investor interest.The sharp rise was primarily driven by the company's reported significant improvement in...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126584549","title":"Large Model Concept Stocks Show Strong Performance Before Noon, with DIAGENS-B and KNOWLEDGE ATLAS Both Rising Over 15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126584549","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126584549?lang=en_us&edition=fundamental","pubTime":"2026-04-08 11:50","pubTimestamp":1775620218,"startTime":"0","endTime":"0","summary":"Large model concept stocks demonstrated robust performance in the morning session before noon. DIAGENS-B increased by 14.96%, reaching 269 HKD. KNOWLEDGE ATLAS rose by 14.63%, trading at 893 HKD. MiniMax advanced by 7.64%, with its price at 1022 HKD.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02513","BK1117","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129482998","title":"DIAGENS-B Shares Surge Over 7% on Strong AI Medical Imaging Foundation Model","url":"https://stock-news.laohu8.com/highlight/detail?id=1129482998","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129482998?lang=en_us&edition=fundamental","pubTime":"2026-04-08 09:54","pubTimestamp":1775613258,"startTime":"0","endTime":"0","summary":"Shares of DIAGENS-B (02526), known as the first listed company focused on medical imaging large models, rose more than 7% in morning trading. At the time of writing, the stock was up 6.84% to HK$250,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIPO","AGIX","BK4588","02526","ARTY","BK1189","02251","VXUS","CHAT","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162374303","title":"Diagens Issues FY2025 Results Notice; Full Annual Report to be Released by 30 April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1162374303","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162374303?lang=en_us&edition=fundamental","pubTime":"2026-03-31 20:05","pubTimestamp":1774958753,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (Diagens) has issued an announcement pursuant to the Note to Rule 13.49(1) of the Hong Kong Listing Rules regarding its financial results for the year ended...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1120317325","title":"Medical Imaging AI Pioneer DIAGENS-B Soars 121% in Hong Kong IPO Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1120317325","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120317325?lang=en_us&edition=fundamental","pubTime":"2026-03-30 11:41","pubTimestamp":1774842103,"startTime":"0","endTime":"0","summary":"The Hong Kong stock market witnessed another milestone in the AI large model sector today. DIAGENS-B officially commenced trading on the Hong Kong Stock Exchange, with its shares priced at HKD 99...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","02251","BK1189"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2623364001","title":"Hangzhou Diagens Biotechnology Soars 121% in Hong Kong Trading Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2623364001","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623364001?lang=en_us&edition=fundamental","pubTime":"2026-03-30 09:46","pubTimestamp":1774835198,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology's (HKG:2526) shares opened 121.2% above their initial public offering price in a stellar Hong Kong debut on Monday morning.The Chinese biotechnology company opened at HK$219.00 per share, compared with the offer price of HK$99.00.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162103240","title":"Stock Track | DIAGENS-B Soars 113.94% on Trading Debut as Medical Imaging AI Firm Opens at Significant Premium to IPO Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1162103240","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162103240?lang=en_us&edition=fundamental","pubTime":"2026-03-30 09:39","pubTimestamp":1774834756,"startTime":"0","endTime":"0","summary":"DIAGENS-B's stock soared 113.94% intraday on Monday as the biotechnology company made its trading debut on the Hong Kong Stock Exchange.The company's initial public offering was priced at HK$99 per...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1146284525","title":"DIAGENS-B (02526) Debuts with 121.21% Surge in Early Trading, Focused on Medical Imaging AI Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1146284525","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146284525?lang=en_us&edition=fundamental","pubTime":"2026-03-30 09:31","pubTimestamp":1774834273,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526) made its trading debut today. According to the company's announcement, the IPO price was set at HKD 99 per share, with a total of 7,999,200 shares issued. Each board lot consists of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251","BK1189","02526"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2623364305","title":"Shares of Shandong Extreme Vision  Set to Open at HK$59.95 Each in Hong Kong Debut VS Offer Price HK$40 Apiece","url":"https://stock-news.laohu8.com/highlight/detail?id=2623364305","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623364305?lang=en_us&edition=fundamental","pubTime":"2026-03-30 09:21","pubTimestamp":1774833674,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nL4N40I04H:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02526","06636","01021","02726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623336322","title":"Diagens Biotechnology Raises HK$719.8 Million From Hong Kong IPO Ahead of Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2623336322","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623336322?lang=en_us&edition=fundamental","pubTime":"2026-03-30 06:15","pubTimestamp":1774822524,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology  raised HK$719.8 million in net proceeds from its initial public offering in Hong Kong.The final offer price was set at HK$99.00 per H-share, according to a Friday after-market filing with the Hong Kong Stock Exchange.The Chinese biotechnology company offered 8.0 million H-shares in the global offering.The Hong Kong public offer was 1,073.37 times subscribed, with a final allocation of 799,950 shares, representing 10% of the total offering.The international offering was 3.45 times subscribed, with a final allocation of 7.2 million shares, or 90% of the total offering.Diagens Biotechnology is scheduled to debut on the Hong Kong bourse on Monday, March 30.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622782982","title":"Hangzhou Diagens Biotechnology - Final Offer Price of HK$99.0 per H Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2622782982","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622782982?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:12","pubTimestamp":1774613567,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40F0CR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":96,"code":"91000000","status":"200"}]}}